Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Diabetes Care|October 30, 2019
Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.SZobair M Younossi, Radhika P Tampi, Andrei Racila, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
Direct and Indirect Economic Burden of Chronic Liver Disease in the United StatesMaria Stepanova, Leyla De Avila, Mariam Afendy, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2009
Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis CZobair M Younossi, Arian Afendy, Maria Stepanova, et al.Journal of Clinical Gastroenterology|June 23, 2016
Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without CirrhosisMehmet Sayiner, Munkhzul Otgonsuren, Rebecca Cable, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2018
Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Issah Younossi, et al.Medicine|November 19, 2016
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV)Pegah Golabi, Elzafir Elsheikh, Azza Karrar, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2020
Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United StatesZobair M Younossi, Maria Stepanova, Janus Ong, et al.Alimentary Pharmacology & Therapeutics|November 15, 2022
Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)Austin Henry, James M Paik, Patrick Austin, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 6, 2018
Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Harry L A Janssen, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 13, 2018
Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis CZobair M Younossi, Maria Stepanova, Rajender Reddy, et al.Pageof 5